Persistent-Asset-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
173
Total Value
118343303
Accession Number
0002056052-25-000002
Form Type
13F-HR
Manager Name
Persistent-Asset-Partners
Data Enrichment
61% identified
105 identified68 unidentified

Holdings

173 positions • $118.3M total value
Manager:
Search and click to pin securities to the top
Page 7 of 9
Gossamer Bio, Inc.
Shares:62.0K
Value:$68.2K
% of Portfolio:0.1% ($68.2K/$118.3M)
00847X904
Shares:310
Value:$64.7K
% of Portfolio:0.1% ($64.7K/$118.3M)
ProQR Therapeutics N.V.
Shares:47.8K
Value:$63.6K
% of Portfolio:0.1% ($63.6K/$118.3M)
90400D908
Shares:270
Value:$61.0K
% of Portfolio:0.1% ($61.0K/$118.3M)
56400P906
Shares:1.2K
Value:$53.9K
% of Portfolio:0.0% ($53.9K/$118.3M)
38341P902
Shares:1.2K
Value:$52.7K
% of Portfolio:0.0% ($52.7K/$118.3M)
NOVO NORDISK A S
Shares:230
Value:$52.2K
% of Portfolio:0.0% ($52.2K/$118.3M)
Eledon Pharmaceuticals, Inc.
Shares:14.9K
Value:$50.4K
% of Portfolio:0.0% ($50.4K/$118.3M)
78464A698
Shares:1.5K
Value:$47.1K
% of Portfolio:0.0% ($47.1K/$118.3M)
02043Q957
Shares:46
Value:$43.0K
% of Portfolio:0.0% ($43.0K/$118.3M)
98985Y908
Shares:184
Value:$40.7K
% of Portfolio:0.0% ($40.7K/$118.3M)
Terns Pharmaceuticals, Inc.
Shares:12.8K
Value:$35.3K
% of Portfolio:0.0% ($35.3K/$118.3M)
717081903
Shares:1.1K
Value:$35.0K
% of Portfolio:0.0% ($35.0K/$118.3M)
Sagimet Biosciences Inc.
Shares:10.6K
Value:$34.5K
% of Portfolio:0.0% ($34.5K/$118.3M)
Candel Therapeutics, Inc.
Shares:5.9K
Value:$33.4K
% of Portfolio:0.0% ($33.4K/$118.3M)
483497903
Shares:241
Value:$32.5K
% of Portfolio:0.0% ($32.5K/$118.3M)
640268908
Shares:1.3K
Value:$30.2K
% of Portfolio:0.0% ($30.2K/$118.3M)
03152W909
Shares:303
Value:$23.5K
% of Portfolio:0.0% ($23.5K/$118.3M)
78462F953
Shares:55
Value:$21.5K
% of Portfolio:0.0% ($21.5K/$118.3M)
75629V904
Shares:700
Value:$21.0K
% of Portfolio:0.0% ($21.0K/$118.3M)